Safe and effective permeation enhancers for oral drug delivery

Pharmaceutical Research

Volumn 25, Issue 8, 2008, Pages 1782-1788

  Whitehead, Kathryn ^a   Karr, Natalie ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

Author keywords

Caco 2; Oral delivery; Permeation enhancers; Potency; Toxicity

Indexed keywords

BENZYLDIMETHYLDODECYLAMMONIUM CHLORIDE; BROMELAIN; CAPROLACTAM; CETRIMIDE; CHOLIC ACID; DECYLDIMETHYLAMMONIOPROPANESULFONATE; DECYLSULFATE SODIUM; DECYLTRIMETHYLAMMONIUM; DEOXYCHLOLATE SODIUM; DEXTRAN; DIETHYL SEBACCATE; DODECYL SULFATE SODIUM; DODECYLPYRIDINIUM CHLORIDE; GLYCOCHOLATE SODIUM; HEPTANOIC ACID DERIVATIVE; HEXANOIC ACID; LAURIC ACID METHYL ESTER; MANNITOL; MYRISTYLDIMETHYLAMMONIOPROPANESULFONATE; MYRISTYLTRIMETHYLAMMONIUM CHLORIDE; N LAURYL SARCOSINATE; NONYLPHENOXYPOLYOXYETHYLENE; OCTYL SULFATE SODIUM; OLEATE SODIUM; PALMITIC ACID METHYL ESTER; PALMITOYLCARNITINE CHLORIDE; PALMITYLDIMETHYLAMMONIOPROPANESULFONATE; PENETRATION ENHANCING AGENT; TRITON X 100; UNINDEXED DRUG;

ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PRIORITY JOURNAL; TOXICITY TESTING;

CACO-2 CELLS; DRUG DELIVERY SYSTEMS; ELECTRIC IMPEDANCE; EPITHELIUM; EXCIPIENTS; HUMANS; INTESTINAL ABSORPTION; PERMEABILITY; STIMULATION, CHEMICAL; TETRAZOLIUM SALTS; THIAZOLES;

EID: 46749122375     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9488-9     Document Type: Article

References (23)

1. M. Goldberg, and I. Gomez-Orellana. Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. 2:289-295 (2003).
2. G. Mustata, and S.M. Dinh. Approaches to oral drug delivery for challenging molecules. Crit. Rev. Ther. Drug Carrier Syst. 23:111-135 (2006).
3. L. Serra, J. Domenech, and N. A. Peppas. Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels. Biomaterials. 27:5440-5451 (2006).
4. S. L. Tao, and T. A. Desai. Gastrointestinal patch systems for oral drug delivery. Drug Discov. Today. 10:909-915 (2005).
5. B. J. Aungst. Intestinal permeation enhancers. J. Pharm. Sci. 89:429-442 (2000).
6. N. N. Salama, N. D. Eddington, and A. Fasano. Tight junction modulation and its relationship to drug delivery. Adv. Drug Deliv. Rev. 58:15-28 (2006).
7. D. Bourdet, G. Pollack, and D. Thakker. Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 Cells. Pharm. Res. 23:1178-1187 (2006).
8. E. S. Swenson, W. B. Milisen, and W. Curatolo. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res. 11:1132-1142 (1994).
9. R. Konsoula, and F. A. Barile. Correlation of in vitro cytotoxicity with paracellular permeability in Caco-2 cells. Toxicol. In Vitro. 19:675-684 (2005).
10. P. Karande, A. Jain, and S. Mitragotri. Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers. J. Control. Rel. 110:307-313 (2006).
11. M. Tomita, M. Hayashi, and S. Awazu. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J. Pharm. Sci. 85:608-611 (1996).
12. E. Fuller, C. Duckham, and E. Wood. Disruption of epithelial tight junctions by yeast enhances the paracellular delivery of a model protein. Pharm. Res. 24:37-47 (2007).
13. E. S. Swenson, and W. Curatolo. Intestinal permeability enhancement for proteins, peptides, and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev. 8:39-92 (1992).
14. N. Frank, H. Achim, S.-H. Georg von, and M. Heinz. Synergistic action of a cyclic depsipeptide and piperazine on nematodes. Pharm. Res. 86:982-992 (2000).
15. J. S. Warrington, L. L. Von Moltke, J. S. Harmatz, R. I. Shader, and D. J. Greenblatt. The effect of age on sildenafil biotransformation in rat and mouse liver microsomes. Drug Metabol. Dispos. 31:1306-1309 (2003).
16. M. J. Fray, G. Bish, P. V. Fish, A. Stobie, F. Wakenhut, and G. A. Whitlock. Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors. Bioorg. Med. Chem. Lett. 16:4349-4353 (2006).
17. K. Whitehead, Z. Shen, and S. Mitragotri. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. J. Control. Rel. 98:37-45 (2004).
18. E. Duizer, C. Van Der Wulp, C. H. M. Versantvoort, and J. P. Groten. Absorption enhancement, structural changes in tight junctions and cytotoxicity caused by palmitoyl carnitine in Caco-2 and IEC-18 cells. J. Pharmacol. Exp. Ther. 287:395-402 (1998).
19. S. Takatsuka, T. Kitazawa, T. Morita, Y. Horikiri, and H. Yoshino. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant. Eur. J. Pharm. Biopharm. 62:52-58 (2006).
20. K. Lindhardt, and E. Bechgaard. Sodium glycocholate transport across Caco-2 cell monolayers, and the enhancement of mannitol transport relative to transepithelial electrical resistance. Int. J. Pharm. 252:181-186 (2003).
21. T. Lindmark, T. Nikkila, and P. Artursson. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J. Pharmacol. Exp. Ther. 284:362-369 (1998).
22. R. B. Shah, A. Palamakula, and M. A. Khan. Cytotoxicity evaluation of enzyme inhibitors and absorption enhancers in Caco-2 cells for oral delivery of salmon calcitonin. J. Pharm. Sci. 93:1070-1082 (2004).
23. M. A. Radwant, and H. Y. Aboul-Enein. The effect of oral absorption enhancers on the in vivo performance of insulin-loaded poly(ethylcyanoacrylate) nanospheres in diabetic rats. J. Microencapsul. 19:225-235 (2002).